BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36283245)

  • 1. Reclassification of risk of malignancy with Percepta Genomic Sequencing Classifier following nondiagnostic bronchoscopy.
    Raval AA; Benn BS; Benzaquen S; Maouelainin N; Johnson M; Huang J; Lofaro LR; Ansari A; Geurink C; Kennedy GC; Bulman WA; Kurman JS
    Respir Med; 2022; 204():106990. PubMed ID: 36283245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study.
    Sethi S; Oh S; Chen A; Bellinger C; Lofaro L; Johnson M; Huang J; Bhorade SM; Bulman W; Kennedy GC
    BMC Pulm Med; 2022 Jan; 22(1):26. PubMed ID: 34991528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
    Lee HJ; Mazzone P; Feller-Kopman D; Yarmus L; Hogarth K; Lofaro LR; Griscom B; Johnson M; Choi Y; Huang J; Bhorade S; Spira A; Kennedy GC; Wahidi MM;
    Chest; 2021 Jan; 159(1):401-412. PubMed ID: 32758562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer.
    Ferguson JS; Van Wert R; Choi Y; Rosenbluth MJ; Smith KP; Huang J; Spira A
    BMC Pulm Med; 2016 May; 16(1):66. PubMed ID: 27184093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical validation of the Percepta genomic sequencing classifier; an RNA next generation sequencing assay for the assessment of Lung Cancer risk of suspicious pulmonary nodules.
    Johnson MK; Wu S; Pankratz DG; Fedorowicz G; Anderson J; Ding J; Wong M; Cao M; Babiarz J; Lofaro L; Walsh PS; Kennedy GC; Huang J
    BMC Cancer; 2021 Apr; 21(1):400. PubMed ID: 33849470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical validation and utility of Percepta GSC for the evaluation of lung cancer.
    Mazzone P; Dotson T; Wahidi MM; Bernstein M; Lee HJ; Feller Kopman D; Yarmus L; Whitney D; Stevenson C; Qu J; Johnson M; Walsh PS; Huang J; Lofaro LR; Bhorade SM; Kennedy GC; Spira A; Rivera MP; ;
    PLoS One; 2022; 17(7):e0268567. PubMed ID: 35830375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing modalities for risk assessment in patients with pulmonary lesions and nondiagnostic bronchoscopy for suspected lung cancer.
    Yu DH; Shafiq M; Batra H; Johnson M; Griscom B; Chamberlin J; Lofaro LR; Huang J; Bulman WA; Kennedy GC; Yarmus LB; Lee HJ; Feller-Kopman D
    BMC Pulm Med; 2022 Nov; 22(1):442. PubMed ID: 36434574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Utility of a Bronchial Genomic Classifier in Patients With Suspected Lung Cancer.
    Vachani A; Whitney DH; Parsons EC; Lenburg M; Ferguson JS; Silvestri GA; Spira A
    Chest; 2016 Jul; 150(1):210-8. PubMed ID: 26896702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Silvestri GA; Vachani A; Whitney D; Elashoff M; Porta Smith K; Ferguson JS; Parsons E; Mitra N; Brody J; Lenburg ME; Spira A;
    N Engl J Med; 2015 Jul; 373(3):243-51. PubMed ID: 25981554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer.
    Feller-Kopman D; Liu S; Geisler BP; DeCamp MM; Pietzsch JB
    J Thorac Oncol; 2017 Aug; 12(8):1223-1232. PubMed ID: 28502850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
    Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
    BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical performance of a bronchial genomic classifier.
    Hu Z; Whitney D; Anderson JR; Cao M; Ho C; Choi Y; Huang J; Frink R; Smith KP; Monroe R; Kennedy GC; Walsh PS
    BMC Cancer; 2016 Feb; 16():161. PubMed ID: 26920854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.
    Voss JS; Iqbal S; Jenkins SM; Henry MR; Clayton AC; Jett JR; Kipp BR; Halling KC; Maldonado F
    Hum Pathol; 2014 Jan; 45(1):41-7. PubMed ID: 24139213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving lung cancer risk stratification leveraging whole transcriptome RNA sequencing and machine learning across multiple cohorts.
    Choi Y; Qu J; Wu S; Hao Y; Zhang J; Ning J; Yang X; Lofaro L; Pankratz DG; Babiarz J; Walsh PS; Billatos E; Lenburg ME; Kennedy GC; McAuliffe J; Huang J
    BMC Med Genomics; 2020 Oct; 13(Suppl 10):151. PubMed ID: 33087128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoscopic diagnosis of solitary pulmonary nodules and lung masses in the absence of endobronchial abnormality.
    Chechani V
    Chest; 1996 Mar; 109(3):620-5. PubMed ID: 8617067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bronchial-airway gene-expression classifier to improve the diagnosis of lung cancer: Clinical outcomes and cost-effectiveness analysis.
    D'Andrea E; Choudhry NK; Raby B; Weinhouse GL; Najafzadeh M
    Int J Cancer; 2020 Feb; 146(3):781-790. PubMed ID: 30977121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy.
    Yung RC
    Respir Care Clin N Am; 2003 Mar; 9(1):51-76. PubMed ID: 12820712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of lung cancer: a bronchoscopist's perspective.
    Griffin JP; Zaman MK; Niell HB; Tolley EA; Cole FH; Weiman DS
    J Bronchology Interv Pulmonol; 2012 Jan; 19(1):12-8. PubMed ID: 23207257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing peripheral lung cancer: the additional value of the Ras-association domain family 1A gene methylation and Kirsten rat sarcoma 2 viral oncogene homolog mutation analyses in washings in nondiagnostic bronchoscopy.
    van der Drift MA; Prinsen CFM; Knuiman GJ; Janssen JP; Dekhuijzen PNR; Thunnissen FBJM
    Chest; 2012 Jan; 141(1):169-175. PubMed ID: 21700687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility and accuracy of rapid on-site evaluation of bronchoscopic brushings.
    Steinfort DP; Leong TL; Laska IF; Beaty A; Tsui A; Irving LB
    Eur Respir J; 2015 Jun; 45(6):1653-60. PubMed ID: 25537567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.